Current Approach to Hepatocellular Carcinoma

被引：51

作者：

Abrams, Peter ^{[1
]}

Marsh, J. Wallis ^{[1
]}

机构：

[1] Univ Pittsburgh, Montefiore Hosp, Sch Med, Dept Surg,Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15215 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2010年 / 90卷 / 04期

关键词：

Hepatocellular carcinoma; Partial hepatectomy; Liver transplantation; Locoregional therapy; Transartenal chemoembolization; Radiofrequency ablation; PERCUTANEOUS RADIOFREQUENCY ABLATION; PRESERVED LIVER-FUNCTION; SURGICAL RESECTION; ADJUVANT THERAPY; WAITING-LIST; RISK-FACTORS; TRANSARTERIAL CHEMOEMBOLIZATION; INTRAHEPATIC RECURRENCE; MULTIVARIATE-ANALYSIS; CIRRHOTIC-PATIENTS;

D O I：

10.1016/j.suc.2010.04.010

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Hepatocellular carcinoma (HCC) accounts for 80% of all primary liver cancers and ranks globally as the fourth leading cause of cancer-related death Partial hepatectomy remains the best treatment option for select patients with HCC without cirrhosis Liver transplantation is well established as the gold standard for patients with HCC and cirrhosis in the absence of extrahepatic spread and macrovascular invasion. Local regional therapy is indicated in select patients who are not surgical candidates, and its role as adjuvant therapy remains to be clarified by prospective studies

引用

页码：803 / +

页数：15

共 72 条

[71] A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy [J].